» Articles » PMID: 30543563

Protein Kinase C-α is Upregulated by IMP1 in Melanoma and is Linked to Poor Survival

Overview
Journal Melanoma Res
Specialty Oncology
Date 2018 Dec 14
PMID 30543563
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The oncofetal mRNA-binding protein, IMP1 or insulin-like growth factor-2 mRNA-binding protein 1 (IGF2BP1), promotes the overexpression of several oncogenic proteins by binding to and stabilizing their mRNAs. IMP1 is frequently overexpressed in melanoma and is associated with a poor prognosis, but the full spectrum of IMP1 target transcripts remains unknown. Here, we report the identification of protein kinase C-α (PKCα), as a novel molecular target of IMP1. Overexpression of IMP1 resulted in increased levels of PKCα, while RNAi knockdown of IMP1 resulted in decreased PKCα mRNA stability, PKCα protein levels, and MAPK/ERK activation. In addition to IMP1 acting as a positive regulator of PKCα mRNA, we also report the identification of miR-340 as a negative regulator of PKCα mRNA. In melanoma cancer cells, inhibition of miR-340 led to increased PKCα protein levels. PKCα plays important roles in numerous signaling pathways including the MAPK/ERK signaling pathway. PKCα activates RAF1, which in turn activates MEK1, and activates downstream transcriptional targets of MAPK through activation of JNK signaling. Together, these pathways provide a way to activate MAPK signaling downstream of BRAF and MEK1 inhibitors, which are commonly used to treat melanoma. Analysis of 117 melanoma tumors samples showed that overexpression of PKCα is associated with poorer overall survival. In patients harboring BRAF or NRAS mutations, PKCα overexpression is associated with an 11-fold increased risk of death. Thus, PKCα mRNA is a novel target of IMP1, which is commonly overexpressed in melanoma and is linked to poorer overall survival.

Citing Articles

PKCα Activation via the Thyroid Hormone Membrane Receptor Is Key to Thyroid Cancer Growth.

Campos Haedo M, Diaz Albuja J, Camarero S, Cayrol F, Sterle H, Debernardi M Int J Mol Sci. 2024; 25(22).

PMID: 39596225 PMC: 11594262. DOI: 10.3390/ijms252212158.


Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer.

Kawano T, Inokuchi J, Eto M, Murata M, Kang J Cancers (Basel). 2022; 14(21).

PMID: 36358843 PMC: 9658272. DOI: 10.3390/cancers14215425.


PPP1R14D promotes the proliferation, migration and invasion of lung adenocarcinoma via the PKCα/BRAF/MEK/ERK signaling pathway.

Cao H, Wang Z, Wang Y, Ye L, Li R, Xue Y Int J Oncol. 2022; 61(6).

PMID: 36263632 PMC: 9635868. DOI: 10.3892/ijo.2022.5443.


Elevated insulin-like growth factor 2 mRNA binding protein 1 levels predict a poor prognosis in patients with breast carcinoma using an integrated multi-omics data analysis.

Li S, Jiang M Front Genet. 2022; 13:994003.

PMID: 36092925 PMC: 9448930. DOI: 10.3389/fgene.2022.994003.


IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma?.

Xi Y, Wang Y Front Pharmacol. 2022; 13:947363.

PMID: 35935853 PMC: 9354603. DOI: 10.3389/fphar.2022.947363.


References
1.
Craig E, Weber J, Spiegelman V . Involvement of the mRNA binding protein CRD-BP in the regulation of metastatic melanoma cell proliferation and invasion by hypoxia. J Cell Sci. 2012; 125(Pt 24):5950-4. PMC: 3585514. DOI: 10.1242/jcs.115204. View

2.
Davies H, Bignell G, Cox C, Stephens P, Edkins S, Clegg S . Mutations of the BRAF gene in human cancer. Nature. 2002; 417(6892):949-54. DOI: 10.1038/nature00766. View

3.
Wen-Sheng W, Jun-Ming H . Activation of protein kinase C alpha is required for TPA-triggered ERK (MAPK) signaling and growth inhibition of human hepatoma cell HepG2. J Biomed Sci. 2005; 12(2):289-96. DOI: 10.1007/s11373-005-1210-5. View

4.
Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, Berninger P . Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell. 2010; 141(1):129-41. PMC: 2861495. DOI: 10.1016/j.cell.2010.03.009. View

5.
Halder K, Banerjee S, Bose A, Majumder S, Majumdar S . Overexpressed PKCδ downregulates the expression of PKCα in B16F10 melanoma: induction of apoptosis by PKCδ via ceramide generation. PLoS One. 2014; 9(3):e91656. PMC: 3954766. DOI: 10.1371/journal.pone.0091656. View